Published April 23, 2021 | Version 2
Dataset Open

Risk of bias assessments for version 4 of the Cochrane review 'Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review'

Creators

  • 1. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • 2. Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
  • 3. Jon J van Rood Center for Clinical Transfusion Research, Sanquin/Leiden University Medical Center, Leiden, Netherlands Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands
  • 4. Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK
  • 5. Clinical, Research and Development, NHS Blood and Transplant, Oxford, UK
  • 6. Sanquin Blood Bank, Amsterdam, Netherlands Erasmus Medical Centre, Rotterdam, Netherlands
  • 7. Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK
  • 8. Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Description

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review (Version 4). 

Files

Files (727.3 kB)

Additional details

Related works

Is supplement to
Journal article: 10.1002/14651858.CD013600.pub4 (DOI)

Funding

European Commission
SUPPORT-E - SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe 101015756